| ETAGX | RRMGX | ETAGX / RRMGX | |
| Total Expense Ratio | 1.43 | 1.31 | 109% |
| Annual Report Gross Expense Ratio | 1.43 | 1.31 | 109% |
| Fund Existence | 17 years | 24 years | - |
| Gain YTD | 11.936 | -0.319 | -3,737% |
| Front Load | 6% | N/A | - |
| Min. Initial Investment | 1000 | 2500 | 40% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 3.05B | 20.8B | 15% |
| Annual Yield % from dividends | 0.00 | 0.00 | - |
| Returns for 1 year | 3.64 | -6.95 | -52% |
| Returns for 3 years | 31.30 | -4.12 | -760% |
| Returns for 5 years | -16.16 | -28.64 | 56% |
| Returns for 10 years | 139.26 | 16.32 | 853% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| TPLGX | 72.27 | 0.43 | +0.60% |
| T. Rowe Price Instl Large Cap Core Gr | |||
| GGOTX | 14.24 | 0.02 | +0.14% |
| Goldman Sachs Mid Cap Growth Inv | |||
| THISX | 94.76 | -0.31 | -0.33% |
| T. Rowe Price Health Sciences I | |||
| BRSBX | 15.73 | -0.08 | -0.51% |
| MFS Blended Research Small Cap Eq B | |||
| ADKSX | 38.03 | -0.26 | -0.68% |
| Adirondack Small Cap | |||